B4GALNT2P1

Across TCGA pan-cancer cohorts, B4GALNT2P1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated B4GALNT2P1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher B4GALNT2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated B4GALNT2P1 expression acts as an unfavorable survival marker.

SKCM, OV, and BRCA are the cancer types where B4GALNT2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.435	0.786	<.001	132	view →
OV	OS	Tertile	II,III,IV	0.365	0.695	<.001	108	view →
BRCA	OS	Tertile	III,IV	0.492	0.836	.005	72	view →
ACC	OS	Tertile	All	0.114	0.892	<.001	72	view →
COAD	OS	Tertile	II,III,IV	0.145	0.850	<.001	54	view →
KIRC	OS	Tertile	All	0.716	0.814	.002	48	view →
HNSC	DFS	Tertile	III,IV	0.448	0.691	.012	21	view →
THCA	OS	Tertile	II,III,IV	0.150	0.902	<.001	21	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	18	view →
STAD	OS	Tertile	IV	0.174	0.463	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

B4GALNT2P1–SKCM (OS)

Open the SKCM breakdown →